Literature DB >> 27682472

Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.

R M Delabre1, N Salez2, N Lapidus1, M Lemaitre3, M Leruez-Ville4, X de Lamballerie2, F Carrat1.   

Abstract

We explored age-dependent patterns in haemagglutination inhibition (HI) titre to seasonal [1956 A(H1N1), 1977 A(H1N1), 2007 A(H1N1)] and pandemic [A(H1N1)pdm09] influenza strains using serological data collected from an adult French influenza cohort. Subjects were recruited by their general practitioners from 2008 to 2009 and followed until 2010. We explored age-related differences between strain-specific HI titres using 1053 serological samples collected over the study period from 398 unvaccinated subjects. HI titres against the tested seasonal and pandemic strains were determined using the HI technique. Geometric mean titres (GMTs) were estimated using regression models for interval-censored data. Generalized additive mixed models were fit to log-transformed HI estimates to study the relationship between HI titre and age (age at inclusion and/or age at initial strain circulation). GMT against one strain was consistently highest in the birth cohort exposed to that strain during childhood, with peak titres observed in subjects aged 7-8 years at the time of initial strain circulation. Our results complete previous findings on influenza A(H3N2) strains and identify a strain-dependent relationship between HI titre and age at initial strain circulation.

Entities:  

Keywords:  Antibodies; H1N1 subtype; cohort studies; immunity; influenza; influenza A virus

Mesh:

Substances:

Year:  2016        PMID: 27682472      PMCID: PMC9507350          DOI: 10.1017/S0950268816002156

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  26 in total

1.  Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

Authors:  M Lemaitre; M Leruez-Ville; X N De Lamballerie; N Salez; P Garrone; A-C Fluckiger; D Klatzmann; F Carrat
Journal:  Clin Microbiol Infect       Date:  2010-10-29       Impact factor: 8.067

2.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

3.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Authors:  D Hobson; R L Curry; A S Beare; A Ward-Gardner
Journal:  J Hyg (Lond)       Date:  1972-12

4.  Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.

Authors:  W P Glezen; W A Keitel; L H Taber; P A Piedra; R D Clover; R B Couch
Journal:  Am J Epidemiol       Date:  1991-02-01       Impact factor: 4.897

5.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Authors:  Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard
Journal:  BMC Med Res Methodol       Date:  2010-03-08       Impact factor: 4.615

6.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Authors:  Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Journal:  Lancet       Date:  2010-01-21       Impact factor: 79.321

7.  Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China.

Authors:  Justin Lessler; Steven Riley; Jonathan M Read; Shuying Wang; Huachen Zhu; Gavin J D Smith; Yi Guan; Chao Qiang Jiang; Derek A T Cummings
Journal:  PLoS Pathog       Date:  2012-07-19       Impact factor: 6.823

8.  Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.

Authors:  Robert B Couch; Robert L Atmar; Luis M Franco; John M Quarles; Diane Niño; Janet M Wells; Nancy Arden; Sheree Cheung; John W Belmont
Journal:  Clin Infect Dis       Date:  2011-11-10       Impact factor: 9.079

9.  Is antigenic sin always "original?" Re-examining the evidence regarding circulation of a human H1 influenza virus immediately prior to the 1918 Spanish flu.

Authors:  Alain Gagnon; J Enrique Acosta; Joaquin Madrenas; Matthew S Miller
Journal:  PLoS Pathog       Date:  2015-03-05       Impact factor: 6.823

10.  Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.

Authors:  Adam J Kucharski; Justin Lessler; Jonathan M Read; Huachen Zhu; Chao Qiang Jiang; Yi Guan; Derek A T Cummings; Steven Riley
Journal:  PLoS Biol       Date:  2015-03-03       Impact factor: 8.029

View more
  1 in total

1.  Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot study.

Authors:  Muriel Fartoukh; Guillaume Voiriot; Laurent Guérin; Jean Damien Ricard; Alain Combes; Morgane Faure; Sarah Benghanem; Etienne de Montmollin; Yacine Tandjaoui-Lambiotte; Antoine Vieillard-Baron; Eric Maury; Jean-Luc Diehl; Keyvan Razazi; Virginie Lemiale; Pierre Trouiller; Benjamin Planquette; Laurent Savale; Nicholas Heming; Jonathan Marey; Fabrice Carrat; Nathanael Lapidus
Journal:  Ann Intensive Care       Date:  2021-07-29       Impact factor: 6.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.